Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

How Has The Patient Risk Stratification Market Size Shifted, And What Is the Outlook Through 2034?

The market size for patient risk stratification has seen rapid expansion in the past few years. There is an anticipated growth from $2.15 billion in 2024 to $2.82 billion in 2025, presenting a compound annual growth rate (CAGR) of 31.3%. The significant growth observed in the past can be associated with a variety of factors such as the rise of digital adoption, higher risk situations, an increase in the elderly population, a higher rate of medical errors, and an elevated level of electronic health record (EHR) utilization.

In the coming years, the market size for patient risk stratification is anticipated to experience substantial growth. By 2029, it’s predicted to expand to $8.30 billion, with a compound annual growth rate (CAGR) of 31.0%. This surge projected within the forecast period can be linked to the rise in middle class and health insurance, increased incidences of chronic diseases, growing engagement with predictive analytics, heightened focus on social determinants of health (SDOH), and broadening application of technology. Key trends expected within the forecast period are enhancements in analytical features, artificial intelligence (AI), machine learning, technological progressions, innovative instruments, advancements in healthcare technology, wearable tech, and remote monitoring.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20917&type=smp

Which Factors and External Forces Are Driving Demand in the Patient Risk Stratification Market?

The escalating incidence of chronic diseases is predicted to drive the expansion of the patient risk stratification market. Chronic conditions are enduring health problems that continue for a protracted period, usually three months or more. Factors contributing to the increased prevalence of chronic diseases include aging populations, unhealthy lifestyles, urbanization, environmental issues, inadequate healthcare access, economic inequality, and heightened stress levels. Patient risk stratification enables the determination of different risk levels for chronic diseases in individuals, thereby facilitating tailored care, early intervention, better resource distribution, and enhanced health outcomes. For example, the National Center for Biotechnology Information’s (NCBI) projection showed in January 2023 that the number of individuals aged 50 and above with at least one chronic disease would surge by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. Moreover, the World Health Organization (WHO) 2022 Highlights reported in September 2022 that 74% of all deaths worldwide were caused by chronic diseases, amounting to 41 million deaths annually. Of these, cardiovascular diseases accounted for 17.9 million deaths, cancer for 9.3 million, chronic respiratory diseases for 4.1 million, and diabetes for 2.0 million. As such, the escalating incidence of chronic diseases is driving the growth of the patient risk stratification market.

Which Segments in the Patient Risk Stratification Offer the Most Growth?

The patient risk stratification market covered in this report is segmented –

1) By Type: Predictive Risk Stratification Model, Retrospective Risk Stratification Model, Prospective Risk Stratification Model, Concurrent Risk Stratification Model

2) By Component: Software, Services

3) By Delivery Model: On-Premise, Cloud-Based

4) By Application: Risk Adjustment, Clinical Workflow, Revenue Cycle Management, Other Applications

5) By End User: Healthcare Providers, Healthcare Payers, Other End Users

Subsegments:

1) By Predictive Risk Stratification Model: Machine Learning-Based Predictive Models, Statistical Predictive Models, AI-Powered Predictive Models

2) By Retrospective Risk Stratification Model: Historical Data-Based Risk Models, Data Mining Retrospective Models

3) By Prospective Risk Stratification Model: Longitudinal Cohort-Based Models, Real-Time Risk Assessment Models

4) By Concurrent Risk Stratification Model: In-Hospital Risk Assessment Models, Real-Time Clinical Decision Support Models

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=20917&type=smp

What Are the Fastest-Growing Geographies in the Patient Risk Stratification Market?

North America was the largest region in the patient risk stratification market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient risk stratification market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing the Patient Risk Stratification Industry Evolution?

Leading organizations in the patient risk stratification sector are prioritizing advancements in healthcare technology like artificial intelligence (AI) for disease screening. This focus aims to optimize early detection, enhance patient results, and curtail healthcare expenses by facilitating precise risk evaluations and personalized treatment plans. AI in disease screening employs complex algorithms and machine learning to scrutinize medical data, thereby enabling early disease detection and enhancing diagnostic precision by swiftly analyzing vast data volumes. To illustrate, in May 2024, WELL Health Technologies Corporation, a healthcare company based in Canada, alongside its investee firm, HEALWELL AI, another Canadian healthcare company with a focus on AI and data science for preventative care, introduced WELL AI Decision Support (WAIDS). This tool targets rare diseases, extending its coverage to chronic conditions such as kidney disease, hypertension, and diabetes. It is capable of identifying over 100 diseases and offers risk stratification, assisting clinicians in identifying care deficiencies and gaining access to actionable data at the care point.

View the full report here:

https://www.thebusinessresearchcompany.com/report/patient-risk-stratification-global-market-report

What Are the Key Elements That Define the Patient Risk Stratification Market?

Patient risk stratification is the process of assessing and categorizing patients based on their risk of experiencing adverse health outcomes. It is used to identify high-risk patients for targeted interventions, optimize resource allocation, facilitate preventive care, improve care coordination, enhance patient outcomes, reduce costs, and support population health management.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20917

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model